1 | CACTIN, FAM32A, SDE2
|
| A human postcatalytic spliceosome structure reveals essential roles of metazoan factors for exon ligation.
|
| Fica SM, Oubridge C, Wilkinson ME, Newman AJ, Nagai K.
|
| Science Feb 15;363(6428):710-714. doi: 10.1126/science.aaw5569. Epub 2019 Jan 3 2019
|
2 | CACTIN, SDE2
|
| Sde2 is an intron-specific pre-mRNA splicing regulator activated by ubiquitin-like processing.
|
| Thakran P, Pandit PA, Datta S, Kolathur KK, Pleiss JA, Mishra SK.
|
| EMBO J. Jan 4;37(1):89-101. doi: 10.15252/embj.201796751. Epub 2017 Sep 25. 2018
|
3 | CACTIN, DHX8, SRRM2
|
| Human cactin interacts with DHX8 and SRRM2 to assure efficient pre-mRNA splicing and sister chromatid cohesion.
|
| Zanini IM, Soneson C, Lorenzi LE, Azzalin CM.
|
| J Cell Sci 130(4):767-778. doi: 10.1242/jcs.194068. Epub 2017 Jan 6.
2017
|
4 | CACTIN, TRIM39
|
| TRIM39 negatively regulates the NFκB-mediated signaling pathway through stabilization of Cactin.
|
| Suzuki M, Watanabe M, Nakamaru Y, Takagi D, Takahashi H, Fukuda S, Hatakeyama S.
|
| Cell Mol Life Sci 73(5):1085-101. doi: 10.1007/s00018-015-2040-x. Epub 2015 Sep 12.
2016
|
5 | CACTIN
|
| Cactin is essential for G1 progression in Toxoplasma gondii.
|
| Szatanek T, Anderson-White BR, Faugno-Fusci DM, White M, Saeij JP, Gubbels MJ.
|
| Mol Microbiol 84(3):566-77. doi: 10.1111/j.1365-2958.2012.08044.x. Epub 2012 Apr 9.
2012
|
6 | CACTIN
|
| Cactin targets the MHC class III protein IkappaB-like (IkappaBL) and inhibits NF-kappaB and interferon-regulatory factor signaling pathways.
|
| Atzei P, Gargan S, Curran N, Moynagh PN.
|
| J Biol Chem 285(47):36804-17. doi: 10.1074/jbc.M110.139113. Epub 2010 Sep 9.
2010
|
7 | ANKRD13A, C14orf131, CACTIN, CCDC34, CEP83, KCTD3, KIF21A, MED6, NEK1, PHF11, PPP2R3B, PPP2R3BY, QTLIGES1, RBM5, RNF12, USP32, YTHDF2, YTHDF2P, ZC3H14, ZKSCAN1, ZNF608
|
| Antigens recognized by autologous antibody in patients with renal-cell carcinoma.
|
| Scanlan MJ, Gordan JD, Williamson B, Stockert E, Bander NH, Jongeneel V, Gure AO, Jager D, Jager E, Knuth A, Chen YT, Old LJ.
|
| Int J Cancer 83(4):456-64. 1999
|